Beovu home Beovu (brolucizumab) is an anti–vascular endothelial growth factor (anti-VEGF) treatment for intraocular use. HAWK & HARRIER Clinical Trial Results Learn more→ Dosing and Administration Learn more→ Safety Profile Learn more→ Beovu 120mg/ml solution for injection pre-filled syringe Learn more→ Rate this content: Select ratingGive Beovu home 1/5Give Beovu home 2/5Give Beovu home 3/5Give Beovu home 4/5Give Beovu home 5/5Noch keine BewertungRate Share Twitter Linkedin Facebook Pinterest Google plus Copy Link Print
